{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:36:44Z","timestamp":1787031404113,"version":"build-2736575974"},"reference-count":50,"publisher":"American Spinal Injury Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"abstract":"\n Background:<\/jats:title>\n Individuals with spinal cord injuries (SCI) experience high rates of prescription opioid use, yet there is limited data on frequency of opioid use and specific medications being taken.<\/jats:p>\n <\/jats:sec>\n \n Objectives:<\/jats:title>\n To examine the frequency of self-reported prescription opioid use among participants with SCI and the relationship with demographic, injury, and socioeconomic characteristics.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A cohort study of 918 adults with SCI of at least 1-year duration completed a self-report assessment (SRA) that indicated frequency of specific prescription opioid use based on the National Survey on Drug Use and Health (NSDUH).<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Forty-seven percent of the participants used at least one prescription opioid over the last year; the most frequently used was hydrocodone (22.1%). Nearly 30% used a minimum of one opioid at least weekly. Lower odds of use of at least one opioid over the past year was observed for Veterans (odds ratio [OR] = 0.60, 95% CI = 0.38, 0.96) and those with a bachelor's degree or higher (OR = 0.63, 95% CI = 0.44, 0.91). When restricting the analysis to use of at least one substance daily or weekly, lower odds of use was observed for those with a bachelor's degree or higher and those with income ranging from $25,000 to $75,000+. None of the demographic or SCI variables were significantly related to prescription opioid use.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Despite the widely established risks, prescription opioids were used daily or weekly by more than 28% of the participants. Usage was only related to Veteran status and socioeconomic status indicators, which were protective of use. Alternative treatments are needed for those with the heaviest, most regular usage.<\/jats:p>\n <\/jats:sec>","DOI":"10.46292\/sci23-00050","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T10:16:30Z","timestamp":1708078590000},"page":"131-139","source":"Crossref","is-referenced-by-count":6,"title":["Self-Reported Prescription Opioid Use Among Participants with Chronic Spinal Cord Injury"],"prefix":"10.46292","volume":"30","author":[{"given":"James S.","family":"Krause","sequence":"first","affiliation":[{"name":"College of Health Professions, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"DiPiro","sequence":"additional","affiliation":[{"name":"College of Health Professions, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E.","family":"Dismuke-Greer","sequence":"additional","affiliation":[{"name":"Health Economics Resource Center, Veterans Affairs Palo Alto, Menlo Park, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25425","reference":[{"key":"b1","series-title":"Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis","author":"US Department of Health and Human Services","unstructured":"US Department of Health and Human Services\n . Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis. https:\/\/www.phe.gov\/emergency\/news\/healthactions\/phe\/Pages\/opioids-7July2021-aspx.aspx"},{"key":"b2","series-title":"US Opioid Dispensing Rate Maps","author":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control","unstructured":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control\n . US Opioid Dispensing Rate Maps. Updated November 10, 2021. https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html"},{"key":"b3","series-title":"Results from the 2021 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2022","unstructured":"Center for Behavioral Health Statistics and Quality\n . Results from the 2021 National Survey on Drug Use and Health: Detailed Tables. 2022. https:\/\/www.samhsa.gov\/data\/report\/2021-nsduh-detailed-tables"},{"key":"b4","series-title":"Drug Overdose Surveillance and Epidemiology (DOSE) System","author":"Centers for Disease Control and Prevention","unstructured":"Centers for Disease Control and Prevention\n . Drug Overdose Surveillance and Epidemiology (DOSE) System. https:\/\/www.cdc.gov\/drugoverdose\/nonfatal\/dashboard"},{"key":"b5","series-title":"Drug Overdose Death Rates","author":"National Institute on Drug Abuse","unstructured":"National Institute on Drug Abuse\n . Drug Overdose Death Rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"b6","series-title":"Prescription Opioid Overdose Death Maps","author":"Centers for Disease Control and Prevention","unstructured":"Centers for Disease Control and Prevention\n . Prescription Opioid Overdose Death Maps. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/prescription\/maps.html"},{"issue":"5","key":"b7","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.apmr.2017.12.004","article-title":"Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury","volume":"99","author":"Hand\n BN","year":"2018","unstructured":"Hand\n BN\n , KrauseJS, SimpsonKN. Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury. Arch Phys Med Rehabil. 2018;99(5):855-861. doi:10.1016\/j.apmr.2017.12.004"},{"issue":"5","key":"b8","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.apmr.2020.10.128","article-title":"Opioid use among individuals with spinal cord injury: Prevalence estimates based on state prescription drug monitoring program data","volume":"102","author":"DiPiro\n ND","year":"2021","unstructured":"DiPiro\n ND\n , MurdayD, CorleyEH, DiPiroTV, KrauseJS. Opioid use among individuals with spinal cord injury: Prevalence estimates based on state prescription drug monitoring program data. Arch Phys Med Rehabil. 2021;102(5):828-834. doi:10.1016\/j.apmr.2020.10.128"},{"key":"b9","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2017.11.018","article-title":"Neuropathic pain and SCI: Identification and treatment strategies in the 21st century","volume":"384","author":"Hatch\n MN","year":"2018","unstructured":"Hatch\n MN\n , CushingTR, CarlsonGD, ChangEY. Neuropathic pain and SCI: Identification and treatment strategies in the 21st century. J Neurol Sci. 2018;384:75-83. doi:10.1016\/j.jns.2017.11.018"},{"issue":"1","key":"b10","series-title":"Pain Ther","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40122-015-0033-y","article-title":"Management of neuropathic pain associated with spinal cord injury","volume":"4","author":"Hagen\n EM","year":"2015","unstructured":"Hagen\n EM\n , RekandT. Management of neuropathic pain associated with spinal cord injury. Pain Ther. 2015;4(1):51-65. doi:10.1007\/s40122-015-0033-y"},{"issue":"2","key":"b11","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1179\/2045772312Y.0000000060","article-title":"The association of opioid use with incident lower extremity fractures in spinal cord injury","volume":"36","author":"Carbone\n LD","year":"2013","unstructured":"Carbone\n LD\n , ChinAS, LeeTA, et al.\n The association of opioid use with incident lower extremity fractures in spinal cord injury. J Spinal Cord Med. 2013;36(2):91-96. doi:10.1179\/2045772312Y.0000000060"},{"issue":"6","key":"b12","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.apmr.2017.12.036","article-title":"Evaluating the use of Medicare Part D in the Veteran population with spinal cord injury\/disorder","volume":"99","author":"Hatch\n MN","year":"2018","unstructured":"Hatch\n MN\n , RaadJ, SudaK, StroupeKT, HonAJ, SmithBM. Evaluating the use of Medicare Part D in the Veteran population with spinal cord injury\/disorder. Arch Phys Med Rehabil. 2018;99(6):1099-1107. doi:10.1016\/j.apmr.2017.12.036"},{"issue":"1","key":"b13","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.apmr.2020.06.020","article-title":"Prevalence of prescribed opioid claims among persons with traumatic spinal cord injury in Ontario, Canada: A population-based retrospective cohort study","volume":"102","author":"Guilcher\n SJT","year":"2021","unstructured":"Guilcher\n SJT\n , HoganME, GuanQ, et al.\n Prevalence of prescribed opioid claims among persons with traumatic spinal cord injury in Ontario, Canada: A population-based retrospective cohort study. Arch Phys Med Rehabil. 2021;102(1):35-43. doi:10.1016\/j.apmr.2020.06.020"},{"key":"b14","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10790268.2022.2084931","article-title":"Assessment of high-risk opioid use metrics among individuals with spinal cord injury: A brief report","author":"DiPiro\n ND","year":"2022","unstructured":"DiPiro\n ND\n , MurdayD, KrauseJS. Assessment of high-risk opioid use metrics among individuals with spinal cord injury: A brief report. J Spinal Cord Med. 2022: 1-5. doi:10.1080\/10790268.2022.2084931"},{"issue":"10","key":"b15","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.apmr.2018.05.013","article-title":"Personality, high-risk behaviors, and elevated risk of unintentional deaths related to drug poisoning among individuals with spinal cord injury","volume":"99","author":"Krause\n JS","year":"2018","unstructured":"Krause\n JS\n , CaoY, DiPiroND, CuddyE. Personality, high-risk behaviors, and elevated risk of unintentional deaths related to drug poisoning among individuals with spinal cord injury. Arch Phys Med Rehabil. 2018;99(10):1941-1948. doi:10.1016\/j.apmr.2018.05.013"},{"key":"b16","series-title":"The 2019 National Survey on Drug Use and Health","author":"National Survey on Drug Use and Health (NSDUH), Center for Behavioral Health Statistics and Quality","unstructured":"National Survey on Drug Use and Health (NSDUH), Center for Behavioral Health Statistics and Quality\n . The 2019 National Survey on Drug Use and Health. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt23057\/NSDUHmrbCAISpecs2019.pdf"},{"key":"b17","series-title":"Pain Med","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnad073","article-title":"Spinal cord injury and prescribed opioids for pain: A scoping review","author":"Shoup\n JA","year":"2023","unstructured":"Shoup\n JA\n , WelterJ, BinswangerIA, et al.\n Spinal cord injury and prescribed opioids for pain: A scoping review. Pain Med. 2023. doi:10.1093\/pm\/pnad073"},{"key":"b18","series-title":"VA\/DoD Clinical Practice Guidelines: Use of Opioids in the Management of Chronic Pain","author":"US Department of Veterans Affairs","year":"2022","unstructured":"US Department of Veterans Affairs\n . VA\/DoD Clinical Practice Guidelines: Use of Opioids in the Management of Chronic Pain. 2022. https:\/\/www.healthquality.va.gov\/guidelines\/pain\/cot\/"},{"issue":"1","key":"b19","series-title":"BMC Health Serv Res","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12913-022-08388-2","article-title":"Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain","volume":"22","author":"Zeliadt\n SB","year":"2022","unstructured":"Zeliadt\n SB\n , DouglasJH, GelmanH, et al.\n Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC Health Serv Res. 2022;22(1):1053. doi:10.1186\/s12913-022-08388-2"},{"issue":"5","key":"b20","series-title":"JAMA Intern Med","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad\n WF","year":"2017","unstructured":"Gellad\n WF\n , GoodCB, ShulkinDJ. Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611-612. doi:10.1001\/jamainternmed.2017.0147"},{"issue":"5","key":"b21","series-title":"Pain","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans","volume":"158","author":"Lin\n LA","year":"2017","unstructured":"Lin\n LA\n , BohnertASB, KernsRD, ClayMA, GanoczyD, IlgenMA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833-839. doi:10.1097\/j.pain.0000000000000837"},{"key":"b22","series-title":"VA reduces prescription opioid use by 64% during past eight years","year":"2020","unstructured":"VA reduces prescription opioid use by 64% during past eight years. 2020. https:\/\/news.va.gov\/press-room\/va-reduces-prescription-opioid-use-by-64-during-past-eight-years\/"},{"issue":"3","key":"b23","series-title":"J Substance Use","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/14659891.2022.2050317","article-title":"Social determinants of opioid use behaviors among adults in the United States","volume":"28","author":"Nicholson\n HL","year":"2023","unstructured":"Nicholson\n HL\n \n . Social determinants of opioid use behaviors among adults in the United States. J Substance Use. 2023\/05\/04 2023;28(3):371-378. doi:10.1080\/14659891.2022.2050317"},{"issue":"5","key":"b24","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41393-020-00605-1","article-title":"Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: A population-based retrospective cohort study","volume":"59","author":"Guan\n Q","year":"2021","unstructured":"Guan\n Q\n , HoganME, CalzavaraA, et al.\n Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: A population-based retrospective cohort study. Spinal Cord. 2021;59(5):512-519. doi:10.1038\/s41393-020-00605-1"},{"issue":"5","key":"b25","series-title":"Am J Drug Alcohol Abuse","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/00952990.2021.1937635","article-title":"Primary prevention of prescription opioid diversion: A systematic review of medication disposal interventions","volume":"47","author":"Sch\u00e4fer\n WLA","year":"2021","unstructured":"Sch\u00e4fer\n WLA\n , JohnsonJK, WaffordQE, PlummerSG, StulbergJJ. Primary prevention of prescription opioid diversion: A systematic review of medication disposal interventions. Am J Drug Alcohol Abuse. 2021;47(5):548-558. doi: 10.1080\/00952990.2021.1937635"},{"key":"b1","series-title":"Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis","author":"US Department of Health and Human Services","unstructured":"US Department of Health and Human Services\n . Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis. https:\/\/www.phe.gov\/emergency\/news\/healthactions\/phe\/Pages\/opioids-7July2021-aspx.aspx"},{"key":"b2","series-title":"US Opioid Dispensing Rate Maps","author":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control","unstructured":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control\n . US Opioid Dispensing Rate Maps. Updated November 10, 2021. https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html"},{"key":"b3","series-title":"Results from the 2021 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2022","unstructured":"Center for Behavioral Health Statistics and Quality\n . Results from the 2021 National Survey on Drug Use and Health: Detailed Tables. 2022. https:\/\/www.samhsa.gov\/data\/report\/2021-nsduh-detailed-tables"},{"key":"b4","series-title":"Drug Overdose Surveillance and Epidemiology (DOSE) System","author":"Centers for Disease Control and Prevention","unstructured":"Centers for Disease Control and Prevention\n . Drug Overdose Surveillance and Epidemiology (DOSE) System. https:\/\/www.cdc.gov\/drugoverdose\/nonfatal\/dashboard"},{"key":"b5","series-title":"Drug Overdose Death Rates","author":"National Institute on Drug Abuse","unstructured":"National Institute on Drug Abuse\n . Drug Overdose Death Rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"b6","series-title":"Prescription Opioid Overdose Death Maps","author":"Centers for Disease Control and Prevention","unstructured":"Centers for Disease Control and Prevention\n . Prescription Opioid Overdose Death Maps. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/prescription\/maps.html"},{"issue":"5","key":"b7","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.apmr.2017.12.004","article-title":"Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury","volume":"99","author":"Hand\n BN","year":"2018","unstructured":"Hand\n BN\n , KrauseJS, SimpsonKN. Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury. Arch Phys Med Rehabil. 2018;99(5):855-861. doi:10.1016\/j.apmr.2017.12.004"},{"issue":"5","key":"b8","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.apmr.2020.10.128","article-title":"Opioid use among individuals with spinal cord injury: Prevalence estimates based on state prescription drug monitoring program data","volume":"102","author":"DiPiro\n ND","year":"2021","unstructured":"DiPiro\n ND\n , MurdayD, CorleyEH, DiPiroTV, KrauseJS. Opioid use among individuals with spinal cord injury: Prevalence estimates based on state prescription drug monitoring program data. Arch Phys Med Rehabil. 2021;102(5):828-834. doi:10.1016\/j.apmr.2020.10.128"},{"key":"b9","series-title":"J Neurol Sci","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2017.11.018","article-title":"Neuropathic pain and SCI: Identification and treatment strategies in the 21st century","volume":"384","author":"Hatch\n MN","year":"2018","unstructured":"Hatch\n MN\n , CushingTR, CarlsonGD, ChangEY. Neuropathic pain and SCI: Identification and treatment strategies in the 21st century. J Neurol Sci. 2018;384:75-83. doi:10.1016\/j.jns.2017.11.018"},{"issue":"1","key":"b10","series-title":"Pain Ther","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40122-015-0033-y","article-title":"Management of neuropathic pain associated with spinal cord injury","volume":"4","author":"Hagen\n EM","year":"2015","unstructured":"Hagen\n EM\n , RekandT. Management of neuropathic pain associated with spinal cord injury. Pain Ther. 2015;4(1):51-65. doi:10.1007\/s40122-015-0033-y"},{"issue":"2","key":"b11","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1179\/2045772312Y.0000000060","article-title":"The association of opioid use with incident lower extremity fractures in spinal cord injury","volume":"36","author":"Carbone\n LD","year":"2013","unstructured":"Carbone\n LD\n , ChinAS, LeeTA, et al.\n The association of opioid use with incident lower extremity fractures in spinal cord injury. J Spinal Cord Med. 2013;36(2):91-96. doi:10.1179\/2045772312Y.0000000060"},{"issue":"6","key":"b12","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.apmr.2017.12.036","article-title":"Evaluating the use of Medicare Part D in the Veteran population with spinal cord injury\/disorder","volume":"99","author":"Hatch\n MN","year":"2018","unstructured":"Hatch\n MN\n , RaadJ, SudaK, StroupeKT, HonAJ, SmithBM. Evaluating the use of Medicare Part D in the Veteran population with spinal cord injury\/disorder. Arch Phys Med Rehabil. 2018;99(6):1099-1107. doi:10.1016\/j.apmr.2017.12.036"},{"issue":"1","key":"b13","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.apmr.2020.06.020","article-title":"Prevalence of prescribed opioid claims among persons with traumatic spinal cord injury in Ontario, Canada: A population-based retrospective cohort study","volume":"102","author":"Guilcher\n SJT","year":"2021","unstructured":"Guilcher\n SJT\n , HoganME, GuanQ, et al.\n Prevalence of prescribed opioid claims among persons with traumatic spinal cord injury in Ontario, Canada: A population-based retrospective cohort study. Arch Phys Med Rehabil. 2021;102(1):35-43. doi:10.1016\/j.apmr.2020.06.020"},{"key":"b14","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10790268.2022.2084931","article-title":"Assessment of high-risk opioid use metrics among individuals with spinal cord injury: A brief report","author":"DiPiro\n ND","year":"2022","unstructured":"DiPiro\n ND\n , MurdayD, KrauseJS. Assessment of high-risk opioid use metrics among individuals with spinal cord injury: A brief report. J Spinal Cord Med. 2022: 1-5. doi:10.1080\/10790268.2022.2084931"},{"issue":"10","key":"b15","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.apmr.2018.05.013","article-title":"Personality, high-risk behaviors, and elevated risk of unintentional deaths related to drug poisoning among individuals with spinal cord injury","volume":"99","author":"Krause\n JS","year":"2018","unstructured":"Krause\n JS\n , CaoY, DiPiroND, CuddyE. Personality, high-risk behaviors, and elevated risk of unintentional deaths related to drug poisoning among individuals with spinal cord injury. Arch Phys Med Rehabil. 2018;99(10):1941-1948. doi:10.1016\/j.apmr.2018.05.013"},{"key":"b16","series-title":"The 2019 National Survey on Drug Use and Health","author":"National Survey on Drug Use and Health (NSDUH), Center for Behavioral Health Statistics and Quality","unstructured":"National Survey on Drug Use and Health (NSDUH), Center for Behavioral Health Statistics and Quality\n . The 2019 National Survey on Drug Use and Health. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt23057\/NSDUHmrbCAISpecs2019.pdf"},{"key":"b17","series-title":"Pain Med","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnad073","article-title":"Spinal cord injury and prescribed opioids for pain: A scoping review","author":"Shoup\n JA","year":"2023","unstructured":"Shoup\n JA\n , WelterJ, BinswangerIA, et al.\n Spinal cord injury and prescribed opioids for pain: A scoping review. Pain Med. 2023. doi:10.1093\/pm\/pnad073"},{"key":"b18","series-title":"VA\/DoD Clinical Practice Guidelines: Use of Opioids in the Management of Chronic Pain","author":"US Department of Veterans Affairs","year":"2022","unstructured":"US Department of Veterans Affairs\n . VA\/DoD Clinical Practice Guidelines: Use of Opioids in the Management of Chronic Pain. 2022. https:\/\/www.healthquality.va.gov\/guidelines\/pain\/cot\/"},{"issue":"1","key":"b19","series-title":"BMC Health Serv Res","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12913-022-08388-2","article-title":"Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain","volume":"22","author":"Zeliadt\n SB","year":"2022","unstructured":"Zeliadt\n SB\n , DouglasJH, GelmanH, et al.\n Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC Health Serv Res. 2022;22(1):1053. doi:10.1186\/s12913-022-08388-2"},{"issue":"5","key":"b20","series-title":"JAMA Intern Med","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad\n WF","year":"2017","unstructured":"Gellad\n WF\n , GoodCB, ShulkinDJ. Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611-612. doi:10.1001\/jamainternmed.2017.0147"},{"issue":"5","key":"b21","series-title":"Pain","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans","volume":"158","author":"Lin\n LA","year":"2017","unstructured":"Lin\n LA\n , BohnertASB, KernsRD, ClayMA, GanoczyD, IlgenMA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833-839. doi:10.1097\/j.pain.0000000000000837"},{"key":"b22","series-title":"VA reduces prescription opioid use by 64% during past eight years","year":"2020","unstructured":"VA reduces prescription opioid use by 64% during past eight years. 2020. https:\/\/news.va.gov\/press-room\/va-reduces-prescription-opioid-use-by-64-during-past-eight-years\/"},{"issue":"3","key":"b23","series-title":"J Substance Use","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/14659891.2022.2050317","article-title":"Social determinants of opioid use behaviors among adults in the United States","volume":"28","author":"Nicholson\n HL","year":"2023","unstructured":"Nicholson\n HL\n \n . Social determinants of opioid use behaviors among adults in the United States. J Substance Use. 2023\/05\/04 2023;28(3):371-378. doi:10.1080\/14659891.2022.2050317"},{"issue":"5","key":"b24","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41393-020-00605-1","article-title":"Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: A population-based retrospective cohort study","volume":"59","author":"Guan\n Q","year":"2021","unstructured":"Guan\n Q\n , HoganME, CalzavaraA, et al.\n Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: A population-based retrospective cohort study. Spinal Cord. 2021;59(5):512-519. doi:10.1038\/s41393-020-00605-1"},{"issue":"5","key":"b25","series-title":"Am J Drug Alcohol Abuse","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/00952990.2021.1937635","article-title":"Primary prevention of prescription opioid diversion: A systematic review of medication disposal interventions","volume":"47","author":"Sch\u00e4fer\n WLA","year":"2021","unstructured":"Sch\u00e4fer\n WLA\n , JohnsonJK, WaffordQE, PlummerSG, StulbergJJ. Primary prevention of prescription opioid diversion: A systematic review of medication disposal interventions. Am J Drug Alcohol Abuse. 2021;47(5):548-558. doi: 10.1080\/00952990.2021.1937635"}],"container-title":["Topics in Spinal Cord Injury Rehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/30\/1\/article-p131.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/tscir\/article-pdf\/30\/1\/131\/3329922\/i1945-5763-30-1-131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/30\/1\/article-p131.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/30\/1\/article-p131.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:51:30Z","timestamp":1775145090000},"score":1,"resource":{"primary":{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/30\/1\/article-p131.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":50,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.46292\/sci23-00050","relation":{},"ISSN":["1082-0744","1945-5763"],"issn-type":[{"value":"1082-0744","type":"print"},{"value":"1945-5763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}